Blue Horseshoe Stocks

Medical Marijuana Round-Up Report Vol. IV

It’s time again for yet another installment of our Medical Marijuana Round-Up Report, when we take a look at all of the plays that we’ve been tracking for the past several months in the rapidly burgeoning cannabis industry. Since early this fall, we have been able to achieve incredible percentage gains from this group of cannabis stocks:

Hemp, Inc. HEMP

When we initially began covering HEMP, the stock was as low as .027. It made a solid run all the way up to .09 before consolidating to bounce off of .037, at which point we saw another jump to .065. Consolidation occurred yet again, however it has rarely dipped below our price at coverage initiation of .027.

Yesterday, the stock surged as much as 37%, running into resistance at the 50DMA (also the HOD) of .037. It ended up closing at .034, a 23% gain on the day. In order to see some added gains here we need to breach the 100 & 50DMA’s at .036 & .037.
___

Medical Marijuana, Inc. MJNA

MJNA has been a freight train over the past several days; we’ve seen positive moves every single day this week. Having broken through it’s previous high in the .16’s on Wednesday, the stock entered blue-sky breakout mode, and has traded extremely high volume over the past three sessions.

There is a lot of momentum in this stock, however when we do see a pullback, we’d like to have the previous resistance level at .162 hold as a future level of support. Below that, we have the 20DMA as support at .14. Volume of this magnitude for the latter portion of the week, is sure to spill over into Monday, so it is highly likely that MJNA will be at or near the tops of our watchlists.

___

Cannabis Science, Inc. CBIS

The first time we mentioned CBIS, we saw a 150% spike from .04-.10. Since then it has held support at .048, and yesterday we had a high, momentum-fueled bounce. The stock broke through the 20, 50 & 100DMA’s and ran into resistance at the 200DMA of .06, where it closed. That represents a gain of 25% from our recent support level.

CBIS is originator the Phytiva line of hemp-based products that was recently acquired by our next big winner, XCHC.

___

X-Change Corporation XCHC

We began talking about XCHC on Monday, having not dropped our focus from it all week, and were duly rewarded for our persistence. Monday’s session brought a move opened from .0699 to .079 (+13%), pulled back to a low of .056, before running back to .0699 (+25%), bringing in a total of 38% on our first day of coverage.

On Wednesday it saw a low of .0521, and surged rapidly yesterday to hit a high of .075, representing an added gain of 44%, and bringing our cumulative gains for the week to a very respectable 82%

Yesterday’s News:

DALLAS, Jan. 31, 2013 /PRNewswire via COMTEX/ — X-Change Corporation (OTCQB:XCHC), a U.S. publicly-traded company, through its European joint venture with Dupetit Natural Products, GmbH, announces that within one week the Company will move into the testing stage of development of its unique hemp-based Phytiva brand of products, as the Company prepares to bring these products to European and North American markets.

___

Foy-Johnston, Inc. FOYJ
While not cannabis-related, we had to make a quick mention of FOYJ, our point of focus for yesterday’s session. We began monitoring the stock on Jan.14-15th when it appeared in our extended watchlist with a price as low as .0006.

Yesterday FOYJ gapped up to .0019 from the previous day’s close of .0014. It ran to .0024 before it dipped to low of .0013, and followed that with a bounce as high as .0018. For the ones lucky enough to catch the .0006 bottom, you could have been looking at gains in excess of 300% at yesterday’s high. During that process, savvy timing on subsequent bounces could have brought gains of as much as 65%

Extended Watchlist:
APPA, MYRY, ABIO, TSYS, HEB, PACD, SIPC

FOYJ | Foy-Johnston, Inc. & Extended Watchlist

Foy-Johnston, Inc. FOYJ

FOYJ appeared on our extended watchlist on January 14-15th, when we saw the stock running into resistance at .0009. It was as low as .0006 at the time, and yesterday the stock hit a high of .0015, representing a move of 150%

Now that has broken its previous resistance point .0012, it seems the may be gearing up for blue sky breakout mode, putting us on high alert. We’d like to see the .0012 level hold as support moving forward.

Yesterday following the market close, we saw a PR hit the wires, with a letter to the shareholders. “The company secured its initial exploration project in the country of Cameroon which is located in West Africa, in an area long known for its prolific mineralization. This part of Africa has been extracting gold and other precious minerals for centuries. The Company is currently in the process of acquiring several significant mining concessions in Cameroon as a result of initial exploratory work programs that were conducted over the past several months.”

We always like to monitor a situation carefully following untraded-upon news.

BARCHART.COM is currently giving FOYJ a 96% Overall “Buy” Rating

Extended Watchlist:
CIRC, ENTB, XCHC, ORCC, KERX

BMSN, KERX & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

BMSN has been a main point of focus for us this year. We first began paying close attention to BMSN towards the end of 2012 when it was trading as low as .0003. Yesterday, the stock had another rockstar performance, reaching new highs and cracking through another major resistance point at .0035 (200DMA).

After the initial surge we saw from .0003-.0024, we wanted to see support hold off of .001. Now that we have hit new highs, we are raising the bar and looking for new support to hold at .0035, or below that, the 20DMA of .0021. If we can see these areas hold as support, we are going to remain bullish on BMSN.

Over the span of our coverage on BMSN, we have been afforded the opportunity at an accumulation of up to 1400% in possible gains from .0003 to yesterday’s high of .0045

Most Recent News:

SAN DIEGO, CA, Jan 24, 2013 (MARKETWIRE via COMTEX) — Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific Group Inc. (PINKSHEETS: BMSN), announced today publication in a peer reviewed medical journal the scientific basis for its HemaXellerate(TM) bone marrow failure product. The manuscript is available at http://www.translational-medicine.com/content/pdf/1479-5876-10-231.pdf. The publication is an overview of the Investigational New Drug (IND) application that the company plans to file for initiating clinical trials.

Keryx Biopharmaceuticals, Inc. KERX

KERX earned us a spot in the Penny Stock Rumble on Tuesday, racking up another solid day of gains, and hitting a high of 8.79. That brings our total possible profits to a very respectable 154%

We are going to be monitoring the activity on KERX following yesterday’s announcement regarding the comnpany’s planned $55M public offering.

Yesterday’s News:

NEW YORK, Jan. 29, 2013 /PRNewswire via COMTEX/ — Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced that it has commenced a $55 million underwritten public offering of shares of its common stock. In connection with this offering, Keryx expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. J.P. Morgan is acting as the sole book-running manager in the offering.

Extended Watchlist:
SCXN, ITNS, MYRY, SWVI, ONCI, ENTB

XCHC, TSOI, KERX & Extended Watchlist

The X-Change Corporation XCHC

Yesterday, following our alert on XCHC, the stock opened up at .0699, and subsequently hit a high of .079 (+13%) where it ran into some resistance. It then pulled back to .056 before running back to its opening price of .0699 (+25%). We’d call that a solid first day, with total gains of up to 38% presenting themselves.

In press release published yesterday, the company announced its plans to roll out its Phytiva products in S. California. The second announcement of its kind in the last week, we can see that XCHC is rigorously pursuing its quest to expand its recently acquired line.

DALLAS, Jan. 28, 2013 /PRNewswire via COMTEX/ — X-Change Corp. (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is extract-based Cosmeceutical and Nutraceuticals solutions through its Phytiva brand product line, announced today that it has been in discussions with California-based cannabis businesses for plans of a full rollout of Phytiva products to consumers in Southern California.The California legal cannabis market is estimated at $12 -$18 billion in total economic activity, supporting 60,000 to 110,000 jobs and $2.5 to $3.5 billion in legal, taxable wages. The cannabis industry is a much needed windfall for the State of California which is in economic distress. Further, the industry would generate additional income and business taxes for the state. California is one of the leading states for Medical Cannabis since first legalizing in mid 1990’s.

These inquiries came from conservative, well-managed firms that participate in full legal compliance through their dispensary licenses. They have physical locations in place that will allow X-Change Corporation to market its full line of Phytiva products.
__

You may have missed yesterday’s link to our short video presentation of XCHC, so click here and take a look.
__

Recent News:

For more information, visit: http://www.phytiva.com
__

Therapeutic Solutions International, Inc. TSOI

A few weeks ago, we noticed TSOI coming off its 52-week low of .01. It was January 14th and 15th when we included it in our extended watchlist, and it was trading as low as .0151. Yesterday the stock managed to close at the high of day of .045, breaching its 20, 50 and 100DMA’s. That move represents a possible gain of 198% from our first mention just two weeks prior.

We would like to see support hold at .04, above the moving averages going forward in order for us to remain bullish on TSOI.

Keryx Biopharmaceuticals, Inc. KERX

Speaking of watchlist plays that have made their mark, KERX appeared in our extended watchlist on January 23rd. We’ve since watched it run from a low of 3.46, and we are now observing pre- market trading at 7.03, a gain of 103%

Extended Watchlist:
MYRY, IFLM, MILV, PLXT

The X-Change Corporation XCHC | Today’s Focus

The X-Change Corporation XCHC

This morning’s new pick, XCHC, really has us interested at the moment. If you’ve been following us for awhile, chances are you recall our mentioning various medical marijuana related stocks. We’ve been heavily monitoring this up-and-coming market sector for quite some time, as legalization has grown as a topic of mainstream political discussion, and in certain states, has become a reality. This has investors looking at related stocks more now than ever before. For anyone looking for a way to get involved in this growing trend, companies like XCHCare a great place to start.__

These companies are our golden ticket to get in on the ground floor of a burgeoning industry. People have known about the versatility and usefulness of hemp for ages, but the window of opportunity for organizations to capitalize on its use is only just beginning to open wide.

Starting on October 16th, we’ve published several reports following medical marijuana plays, including Cannabis Science, Inc. (OTCQB:CBIS) on several occasions. It was a stock that provided us with a lot of good opportunities for gain, including a 150% rip from .04 to .10 back in November. Today’s new interest, The X-Change Corporation, recently acquired CBIS’s “Phytiva” Brand of products, including all associated rights and companies. Phytiva is a line of hemp-based personal care products that includesLip Balm, Moisturizing Cream, SunScreen, and an Anti-Aging Serum.

With conservative estimates placing the value of the cannabis sector at roughly $40B a year, and the personal care/anti-aging industry at a whopping $350B, there is no doubt that XCHC is a promising prospect in an extremely desirable, not to mention fashionable, market space.

As it turns out, we are focusing on XCHC at a good time with regard to the conditions on the chart. The RSI is beginning to appear oversold, the Slow STO is pinching in for a cross, and as you can see by our annotations below, we are observing a descending wedge pattern as the stock gears up for its run.

We also had a short video presentation of XCHC prepared, so click here and take a look.